Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2018-02-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specifically, continuous beat-by-beat blood pressure readings against arterial catheter readings, continuous beat-by-beat left ventricular ejection times (LVET) against matching LVETs obtained from central catheters, cardiac output (CO) and stroke volume (SV) measures against thermo-dilution and Fick measurements, and standard HRV parameters based on Caretaker-provided inter-beat intervals (IBI) against the same HRV parameters obtained from ECG-based IBIs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Comparison of blood pressure, LVET and CO/SV measures with respective Gold Standards
Non-invasive hemodynamic measurements
Non-invasive hemodynamic measurements
Group 2
Comparison of blood pressure and HRV measures with respective Gold Standards
Non-invasive hemodynamic measurements
Non-invasive hemodynamic measurements
Group 3
Comparison of blood pressure and CO/SV measures with respective Gold Standards
Non-invasive hemodynamic measurements
Non-invasive hemodynamic measurements
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-invasive hemodynamic measurements
Non-invasive hemodynamic measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* \<18 years of age
* No or poor finger pulse, as determined through visual inspection for ischemic hands
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Virginia
OTHER
Yale University
OTHER
Orange County Research Center
OTHER
CareTaker Medical LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Baruch, PhD
Role: PRINCIPAL_INVESTIGATOR
Caretaker Medical
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caretaker Medical
Charlottesville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hemo_001
Identifier Type: -
Identifier Source: org_study_id